| 2023-05-03 | Sale | Bristol-Myers Squibb Company BMY | EVP & President, Research | 50,385 0.0024% | $67.06 | $3.38M | -19.35% | |
| 2022-11-07 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 45,910 0.0022% | $78.88 | $3.62M | -14.63% | |
| 2022-03-16 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 31,331 0.0015% | $69.27 | $2.17M | +7.64% | |
| 2021-12-16 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 19,298 0.0009% | $61.99 | $1.2M | +20.33% | |
| 2021-07-30 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 316,786 0.0143% | $68.07 | $21.56M | +0.22% | |
| 2021-05-05 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 61,092 0.0027% | $64.29 | $3.93M | +2.78% | |
| 2020-11-23 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 26,842 0.0012% | $61.34 | $1.65M | +2.68% | |
| 2020-11-19 | Sale | Bristol-Myers Squibb Company BMY | EVP, Research & Early Dev. | 115,182 0.005% | $61.30 | $7.06M | +2.4% | |
| 2020-03-02 | Sale | Bristol-Myers Squibb Company BMY | Pres., Research & Early Dev. | 168,616 0.0075% | $60.59 | $10.22M | +2.16% |